Study of Colorectal Anastomosis Failures With First Sigmoid or Left Colonic Artery Preservation With D3 Lymphadenectomy
COLAP-D3
A Randomized Multicenter Prospective Study of Colorectal Anastomosis Failures With First Sigmoid or Left Colonic Artery Preservation With D3 Lymphadenectomy (COLAP-D3 - Colorectal Anastomotic Leakage and Arterial Preservation With D3 Lymphadenectomy)
1 other identifier
interventional
778
1 country
1
Brief Summary
This study is a randomized, controlled trial comparing the short- and long-term outcomes of left colonic artery or first sigmoid artery preservation for rectal surgery. Eligible patients will be randomized to D3-lymphodissection with preservation of the first sigmoid artery or left colonic artery in a 1:1 ratio according to a computer-generated randomization list created in advance (includes removal of 252, 253 l/u groups, 241 groups of distal sigmoid colon sites when the neoplasm is highly located). The operation involves removal of the tumor with oncologically adequate clearance, adherence to the principles of operation in embryonic layers. The criterion for performing D3-lymphodissection is visualization of the site of the inferior mesenteric artery (IMA) branching from the aorta. During the surgical intervention, l/u groups 252 and 253 are elevated along the superior rectus artery, the NBA is skeletonized circularly so that there are no l/u and no visible areas of fatty tissue. In the group with preservation of the left colonic artery, the NBA is isolated, clipped and crossed immediately after the LCA, and in the group with preservation of the first SA, the NBA is skeletonized to the level of the first sigmoid artery, clipped and crossed immediately after the first sigmoid artery . After the intestinal resection stage, a colorectal anastomosis is formed, information on drain placement. The primary endpoint is to assess the incidence of IA - communication of the intraluminal compartment of the intestine with the extraluminal compartment, anastomosis leakage in the area of the formed anastomosis - which will be performed at 30 days postoperatively and categorized according to the Clavien-Dindo scale. HA can be diagnosed by MRI, CT with proctography, endoscopic examination, or patient examination (if low anastomoses are formed). Any adverse event in the postoperative period is also classified according to the Clavien-Dindo scale and recorded in the individual patient's chart. Each patient will have an individual electronic record (eCRF open clinica.), where individual patient data will be entered and where the data obtained will be stored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
April 22, 2025
March 1, 2025
3.1 years
March 26, 2025
April 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Failure of colorectal anastomoses within 30 days of surgery
The failure of colorectal anastomosis will be registered in the presence of clinical symptoms confirmed by rectal examination (with low anastomoses) and/or MRI
3 years
Secondary Outcomes (5)
Assessment of radicality of surgery: number of LU removed
3 years
Long-term results: overall and recurrence-free survival at 1 year, 3 and 5 years, respectively, the percentage of three- and five-year survival in the group where sigmoid artery preservation was performed and where it was clipped.
3 years
Registration of all deviations from the normal course in the postoperative period
3 years
Assessment of radicality of surgery: proximal and distal clearance
3 years
Assessment of radicality of surgery: number of R1 resections
3 years
Study Arms (2)
LCA preserved
ACTIVE COMPARATORA group of people with only the left colonic artery preserved
First SA preserved
ACTIVE COMPARATORA group of people with only the first sigmoid artery preserved
Interventions
This study aims to determine the incidence of anastomosis failure in the group with first SA and LCA preservation in order to identify the feasibility of manipulation. The study is unique in that there is only one study in the world that evaluates the incidence of anastomosis failure with preservation of the first sigmoid and there is no study comparing the groups described in this study.
Eligibility Criteria
You may qualify if:
- Signed informed consent form
- ECOG status is 0-2.
- Age over 18 years
- TNM stage according to version VIII T1b-4aN0-2M0 (M1 in case of resectable metastases confirmed by preoperative staging (colonoscopy, chest and abdominal CT).
- Histologically confirmed adenocarcinoma of the colon, the proximal edge of which is not higher than or equal to 20 cm from the anus
- Clinical indications for colorectal resection with anastomosis formation
You may not qualify if:
- Medical or psychiatric reasons affecting the patient's decision to participate in the study
- Pregnancy or breastfeeding
- Medical conditions contraindicated for surgery
- Synchronous or metachronous malignancies
- Acute intestinal obstruction, bleeding or perforation
- Preplanned obstructive bowel resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beloostrov Clinic High Tech
Saint Petersburg, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Timur Lankov The head of the Department of Abdominal and Thoracic Oncology
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 22, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2029
Last Updated
April 22, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share